Table: Peptidream -9-MTH group results (IFRS)

PeptiDream

12/11/2025 06:31

Nov 12 (Reuters)- 
              Peptidream Inc. 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2025        Sep 30, 2024     Dec 31, 2025 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales               12.86               41.60            49.00    
                   (-69.1 pct)         (+84.5 pct)      (+5.0 pct)  
  Operating         loss 4.06             24.52            21.60    
                                      (+263.1 pct)      (+2.3 pct)  
  Pretax            loss 4.34             24.30            21.20    
                                      (+421.3 pct)      (+1.5 pct)  
  Net               loss 3.22             17.62            15.10    
                                      (+397.6 pct)      (+0.6 pct)  
  EPS Basic      loss 24.88 yen        135.95 yen                   
  EPS Diluted    loss 24.88 yen        135.76 yen                   
  Ann Div                                  NIL              NIL     
  -Q2 Div              NIL                 NIL                      
  -Q4 Div                                  NIL              NIL     
 
  NOTE - Peptidream Inc.. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4587.T